ArticleOncotarget2014
Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer.
Hong Hua Yan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleOncotarget2014
Hong Hua Yan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.